Sow 2006.

Methods	A RCT to compare AZT+3TC+NVP versus AZT+3TC+EFV among 70 HIV‐infected patients in Senegal Age limits not given.
Participants	70 ART treatment‐naïve patients from Senegal
Interventions	AZT 300 mg, 3TC 150 mg and NVP 200 mg (N = 35) on one hand versus AZT 300 mg, 3TC 150 mg, and EFV 600 mg (N = 35)
Outcomes	Decrease in viral burden, side‐effects and change in CD4 count. Follow‐up was for 76 weeks.
Notes	This trial was reported in abstract form.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	The trial authors did not report this information.
Allocation concealment (selection bias)	Unclear risk	The trial authors did not report this information.
Blinding (performance bias and detection bias) All outcomes	Unclear risk	The trial authors did not report this information.
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	The trial authors did not report this information.
Selective reporting (reporting bias)	Unclear risk	The trial authors did not report this information.
Baseline data reported?	Unclear risk	The trial authors did not report this information.
Other bias	Unclear risk	The trial authors did not report this information.